Phase 1 Study Of The Antibody-Drug Conjugate Sgn-Liv1a In Patients With Heavily Pretreated Triple-Negative Metastatic Breast Cancer
CANCER RESEARCH(2018)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined